#Timothy Ray Brown

Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.

A second man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.

Perhaps amfAR sums it up best: “We’re certainly hopeful.”

Timothy Brown may have company after a man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.

Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.

Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.

So why is he taking meds every day?

USCA2015 focuses on disparities in epidemic and includes a master lecture series, an HIV action day, workshops, an exhibit hall and more.

A small primate study has suggested that the radiation element of the leukemia treatment that Timothy Ray Brown (a.k.a. the Berlin Patient) re...

A primate study has suggested that the radiation part of the leukemia treatment the “Berlin patient” received was not what functio...

The first man cured of HIV shares his experiences in a book excerpt.

Timothy Brown—a.k.a. “the Berlin Patient”—is the Man Who Once Had HIV.

I was diagnosed with HIV in 1996, the official midpoint for the epidemic to date.

One man’s cure could lead to a cure for all.

The “Berlin Patient”—a man living with HIV who underwent a transplant involving HIV-resistant stem cells in 2007 for the tre...